Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs

Mise à jour : Il y a 5 ans
Référence : EUCTR2009-012003-26

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

- To evaluate the effects of risperidone as compared with other atypical antipsychotic medications on child growth and sexual maturation -To evaluate the risk of other prolactin-related adverse events associated with risperidone as compared with other atypical antipsychotic medications in a pediatric population


Critère d'inclusion

  • Long-term safety data in children and adolescents will be collected from a population of patients with a diagnosis of schizophrenia, bipolar mania, autistic disorder or conduct and other disruptive disorders undergoing routine standard of care treatment